TriSalus Life Sciences’ Post

Zachary Berman from UCSD used the NEW TriNav LV® Infusion System to deliver resin Y90 TARE to treat metastatic leimyosarcoma. Side-by-side imaging from the case shows how TriNav LV with its Pressure-Enabled Drug Delivery approach significantly improved the tumor targeting compared to a traditional microcatheter, while decreasing delivery to the normal liver – effectively increasing the T:N ratio. Read the full case study and see all the imaging here: https://lnkd.in/gDusCY2W TriNav LV is recommended for vessel sizes 3.5mm to 5.0mm, and is now available. #TriNav #Irad #InterventionalOncology

  • No alternative text description for this image
Jason Pacheco

Medical Device Sr. Territory Manager | Top Salesman | Disruptive Product Launches | President’s Club | Endovascular AAA TAA | Interventional Oncology | Peripheral Vascular Disease | Wellness Coaching

2w

Congrats Dr Berman and TriSalus (Bren too)

Like
Reply

To view or add a comment, sign in

Explore topics